PATH | VRL
Menu

Find resources

Total results with these characteristics: 150

Topic: Immunization financing

Page 1 of 8
2014 Assessment Report of the Global Vaccine Action Plan: Strategic Advisory Group of Experts on Immunization

The Global Vaccine Action Plan (GVAP) was endorsed by the World Health Assembly in May 2012 to achieve its “Decade of Vaccines” vision of universal access to immunization. This report provides a review of the progress on implementation of the …

Author: World Health Organization

Publication date: 2014

Access to Vaccines Index 2017

The Access to Vaccines Index is a publicly available tool that assesses the world's largest vaccine companies based on their ability to improve access to vaccines. With cross-cutting analyses of each vaccine company's efforts to develop, …

Author: Access to Medicine Foundation

Publication date: 2017

The Advance Market Commitment Pilot for Pneumococcal Vaccines: Outcomes and Impact Evaluation

This report assesses the extent to which the Advanced Market Commitment (AMC) pilot program has achieved its stated objectives and overarching goal of reducing morbidity and mortality from pneumococcal disease by accelerating the development, …

Author: The Boston Consulting Group

Publication date: 2015

Advance Market Commitments for Vaccines

This informative fact sheet provides a definition of Advance Market Commitments as a potential financing mechanism for bringing new vaccines to the developing world and also outlines World Health Organization's position on the mechanism.

Author: World Health Organization

Publication date: 2006

An Analysis of Government Immunization Program Expenditures in Lower and Lower Middle Income Countries 2006-12

This article, published in Health Policy and Planning, examines the rising costs of immunization as new, more expensive vaccines are introduced into national immunization programs. The authors estimate that, by 2015, immunization costs will likely …

Author: Nader AA, de Quadros C, Politi C, McQuestion M

Publication date: 2015

Analysis of Immunization Financing Indicators of the WHO-UNICEF Joint Reporting Form (JRF), 2006-2012

This report presents an analysis of global and regional trends in key financing indicators, which are used to examine the financial sustainability of immunization programs, for the period of 2006 to 2012. The financing indicators aim to capture the …

Author: World Health Organization

Publication date: 2014

Andhra Pradesh: Building a Model Immunization System

This report discusses the work of PATH's Children's Vaccine Program and the Indian state of Andhra Pradesh to build a model immunization program, including the incorporation of hepatitis B vaccine into the childhood vaccination program.

Author: PATH

Publication date: 2004

Building Next Generation Immunization Supply Chains

This supplement to Vaccine contains 31 articles addressing the role of immunization supply chains (iSC) in expanding vaccine coverage, as well as current challenges, successful pilots, and innovative upstream solutions towards next-generation iSC. …

Author: Lee BY, Schreiber B, Rao R, eds.

Publication date: 2017

The Burden of Pneumococcal Disease and Cost-Effectiveness of a Pneumococcal Vaccine in Latin America and the Caribbean: A Review of the Evidence and a Preliminary Economic Analysis

This report estimates the burden and costs of pneumococcal disease in Latin America and the Caribbean in order to inform national health authorities about disease burden and the economic value of implementing a pneumococcal …

Author: Sabin Vaccine Institute

Publication date: 2007

A Call to Action for the New Decade of Vaccines

This article, published in The Lancet, argues that there is a moral imperative to make vaccines widely available on an equitable basis. The authors lay out a call to action for the new decade of vaccines, which embraces four key elements. First, …

Author: Moxon ER, Das P, Greenwood B, et al.

Publication date: 2011

Cambodia: "Coverage Improvement Planning" Pays Off

This report discusses the work of PATH's Children's Vaccine Program and the Australian International Health Institute of the University of Melbourne to provide technical assistance with immunization programming to Cambodia, including the …

Author: PATH

Publication date: 2004

Can We Defeat Meningococcal Disease in Low and Middle Income Countries?

This article, published in Vaccine, discusses the challenges of achieving control of meningococcal disease in low- and middle-income countries. The authors argue that in low-income countries the main challenge is a lack of sufficient epidemiological …

Author: Greenwood B, Chiarot E, MacLennan CA, O'Ryan M

Publication date: 2012

A Case Study Using the United Republic of Tanzania: Costing Nationwide HPV Vaccine Delivery Using the WHO Cervical Cancer Prevention and Control Costing Tool

This article, published in BMC Medicine, reports on a study to determine the cost of establishing a human papillomavirus (HPV) vaccine program that delivers three doses of vaccine to girls at schools via phased national introduction in Tanzania. It …

Author: Hutubessy R, Levin A, Wang S, et al.

Publication date: 2012

Center for Vaccine Innovation and Access

This website provides information about the work of PATH’s Center for Vaccine Innovation and Access, which brings together expertise across every stage of vaccine research, development, and introduction to make lifesaving vaccines globally …

Author: PATH

Cervical Cancer Prevention and HPV Vaccines

This fact sheet outlines the types of support the GAVI Alliance offers for the introduction of human papillomavirus (HPV) vaccines in eligible countries. It also links to the specific requirements for country applications.

Author: GAVI Alliance

Publication date: 2014

Combatting Japanese Encephalitis in Nepal: A Public Health Success Story

This case study details Nepal’s successful efforts—despite several challenges—against Japanese encephalitis (JE), from establishing disease surveillance to a robust routine JE immunization program.

Author: PATH

Publication date: 2016

Comparative Evaluation of the Potential Impact of Rotavirus Versus HPV Vaccination in GAVI-Eligible Countries: A Preliminary Analysis Focused on the Relative Disease Burden

This article, published in BMC Infectious Diseases, reports on a study that aimed to provide early insight into how the comparative impact of different new vaccines could be assessed in resource-poor settings with respect to affordability, …

Author: Kim SY, Sweet S, Chang J, Goldie SJ

Publication date: 2011

Comparative Review of Three Cost-Effectiveness Models for Rotavirus Vaccines in National Immunization Programs: A Generic Approach Applied to Various Regions in the World

This article, published in BMC Medicine, critically reviews available cost-effectiveness models for rotavirus vaccination, comparing their designs using a standardized approach and studying the similarities and differences in cost-effectiveness …

Author: Postma MJ, Jit M, Rozenbaum MH, Standaert BA, Tu HA, Hutubessy RCW

Publication date: 2011

A Cost Comparison of Introducing and Delivering Pneumococcal, Rotavirus and Human Papillomavirus Vaccines in Rwanda

This article, published in Vaccine, reports on a cost comparison of introducing multiple vaccines in a single country and then assessing the financial and economic impact at the time and implications for the future. The objective of the analysis was …

Author: Ngabo F, Levin A, Wang SA, et al.

Publication date: 2015

A Cost Effectiveness and Capacity Analysis for the Introduction of Universal Rotavirus Vaccination in Kenya: Comparison Between Rotarix and RotaTeq Vaccines

The authors of this article, published in PLoS ONE, applied cost-effectiveness modeling and a cold-chain impact assessment to aid decision-making on rotavirus vaccine introduction in Kenya. They conclude that use of either vaccine is cost-effective, …

Author: van Hoek AJ, Ngama M, Ismail A, et al.

Publication date: 2012

Page 1 of 8